IL42764A - S-adenosyl-2-methionine tri-p-toluene sulfonate,its preparation and therapeutic compositions containing it - Google Patents

S-adenosyl-2-methionine tri-p-toluene sulfonate,its preparation and therapeutic compositions containing it

Info

Publication number
IL42764A
IL42764A IL42764A IL4276473A IL42764A IL 42764 A IL42764 A IL 42764A IL 42764 A IL42764 A IL 42764A IL 4276473 A IL4276473 A IL 4276473A IL 42764 A IL42764 A IL 42764A
Authority
IL
Israel
Prior art keywords
sam
acid
tri
aqueous solution
toluensulphonate
Prior art date
Application number
IL42764A
Other languages
English (en)
Other versions
IL42764A0 (en
Original Assignee
Bioresearch Sas Del Dr Livio C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Sas Del Dr Livio C filed Critical Bioresearch Sas Del Dr Livio C
Publication of IL42764A0 publication Critical patent/IL42764A0/xx
Publication of IL42764A publication Critical patent/IL42764A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • C12P19/40Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL42764A 1972-08-02 1973-07-17 S-adenosyl-2-methionine tri-p-toluene sulfonate,its preparation and therapeutic compositions containing it IL42764A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2779372 1972-08-02

Publications (2)

Publication Number Publication Date
IL42764A0 IL42764A0 (en) 1974-01-14
IL42764A true IL42764A (en) 1976-04-30

Family

ID=11222342

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42764A IL42764A (en) 1972-08-02 1973-07-17 S-adenosyl-2-methionine tri-p-toluene sulfonate,its preparation and therapeutic compositions containing it

Country Status (29)

Country Link
US (1) US3893999A (ro)
JP (1) JPS5235726B2 (ro)
AR (1) AR195350A1 (ro)
AT (1) AT341684B (ro)
AU (1) AU474015B2 (ro)
BE (1) BE802981A (ro)
CA (1) CA1006872A (ro)
CH (1) CH592112A5 (ro)
CS (1) CS195254B2 (ro)
DD (1) DD107461A5 (ro)
DE (1) DE2336401C3 (ro)
DK (1) DK131868C (ro)
ES (1) ES417377A1 (ro)
FI (1) FI52466C (ro)
FR (1) FR2194425B1 (ro)
GB (1) GB1425384A (ro)
HK (1) HK31580A (ro)
HU (1) HU167266B (ro)
IE (1) IE37913B1 (ro)
IL (1) IL42764A (ro)
MX (1) MX4544E (ro)
NL (1) NL152864B (ro)
NO (1) NO137941C (ro)
PL (1) PL87381B1 (ro)
RO (1) RO63451A (ro)
SE (1) SE400085B (ro)
SU (1) SU646915A3 (ro)
YU (1) YU36037B (ro)
ZA (1) ZA734876B (ro)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE39517B1 (en) * 1973-06-27 1978-10-25 Bioresearch Sas Double salts of s-adenosyl-l-methhionine
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
US4109079A (en) * 1975-10-16 1978-08-22 Yamasa Shoyu Kabushiki Kaisha Stabilized s-adenosyl-l-methionine preparations
GB2064523B (en) * 1979-12-04 1983-06-29 Kanegafuchi Chemical Ind Stable composition of s-adenosyl-l-methionine
IT1137640B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1137892B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1139974B (it) * 1981-09-11 1986-09-24 Bioresearch Srl Derivati della s-adenosilmetionina,processo per la preparazione e composizioni terapeutiche che li contengono come principio attivo
IT1169773B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Processo per la produzione di sali stabili della solfo-adenosil-l-metionina
IT1169774B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
AU2538588A (en) * 1987-10-09 1989-05-02 Mario De Rosa Lipophilic salts of s-adenosyl-l-methionine (sam) with acylated taurine derivatives
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
US6759395B2 (en) 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
US8063024B2 (en) * 2005-01-26 2011-11-22 University Of Manitoba Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
ITMI20060629A1 (it) * 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US20080206333A1 (en) * 2007-01-31 2008-08-28 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
US20110027342A1 (en) 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US20140187509A1 (en) * 2011-04-15 2014-07-03 Scimar Ltd. Use of s-adenosylmethionine, vitamin e, and vitamin c for the prevention and treatment of cardiovascular dysfunction
IN2015DN04151A (ro) 2012-10-17 2015-10-16 Methylation Sciences Internat Srl
ES2824807T3 (es) 2013-01-16 2021-05-13 Hebert Sam E Llc Sales de indol-3-propionato estables de S-adenosil-L-metionina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946781A (en) * 1957-02-06 1960-07-26 Merck & Co Inc Process for the preparation of adenosyl homocysteine
US3642772A (en) * 1968-09-04 1972-02-15 Boehringer Mannheim Gmbh Process for preparing s-adenosyl homocysteine

Also Published As

Publication number Publication date
SU646915A3 (ru) 1979-02-05
US3893999A (en) 1975-07-08
PL87381B1 (ro) 1976-06-30
IL42764A0 (en) 1974-01-14
NL152864B (nl) 1977-04-15
AT341684B (de) 1978-02-27
DD107461A5 (ro) 1974-08-05
JPS4992215A (ro) 1974-09-03
JPS5235726B2 (ro) 1977-09-10
SE400085B (sv) 1978-03-13
GB1425384A (en) 1976-02-18
DE2336401B2 (de) 1979-07-12
DK131868B (da) 1975-09-15
DE2336401A1 (de) 1974-02-14
IE37913B1 (en) 1977-11-09
YU36037B (en) 1981-11-13
ES417377A1 (es) 1976-02-16
NO137941C (no) 1978-05-31
CS195254B2 (en) 1980-01-31
ZA734876B (en) 1974-06-26
BE802981A (fr) 1973-11-16
NO137941B (no) 1978-02-13
HU167266B (ro) 1975-09-27
FR2194425B1 (ro) 1976-04-09
AU474015B2 (en) 1976-07-08
FI52466B (ro) 1977-05-31
FR2194425A1 (ro) 1974-03-01
DK131868C (da) 1976-03-08
RO63451A (fr) 1978-07-15
HK31580A (en) 1980-06-20
AR195350A1 (es) 1973-09-28
FI52466C (fi) 1977-09-12
CH592112A5 (ro) 1977-10-14
YU203073A (en) 1981-04-30
NL7310706A (ro) 1974-02-05
DE2336401C3 (de) 1980-03-13
MX4544E (es) 1982-06-08
ATA664173A (de) 1977-06-15
AU5868073A (en) 1975-01-30
IE37913L (en) 1974-02-02
CA1006872A (en) 1977-03-15

Similar Documents

Publication Publication Date Title
IL42764A (en) S-adenosyl-2-methionine tri-p-toluene sulfonate,its preparation and therapeutic compositions containing it
Glinsukon et al. Acute toxicity of capsaicin in several animal species
KR870006074A (ko) 고순도 아카르보스 및 그의 제조방법
NO154344B (no) Analogifremgangsmaate for fremstilling av antivirale amin- og amidin-derivater.
PT1667960E (pt) Métodos para a preparação de sais de meldonium e composições farmacêuticas com base nos mesmos
EP0164998A2 (en) Compositions and methods of enhancing transdermal and transmembrane penetration of topical and systemic agents
CN108078969B (zh) 萘酰肼类化合物在制备抗微生物药物中的用途
GB1335783A (en) Anti-seborrhoeic compositions
Gupta et al. Antiinflammatory activity of some active principles of Lawsonia inermis leaves
US4185120A (en) Topical treatment of fungal or yeast infections using p-tolyl diiodomethyl sulfone
GB977214A (en) Chemical compounds
EP0214357B1 (en) Novel chemical compound having antimycotic, cicatrizing and antiinflammatory activity
CN107753469B (zh) Ndga类似物在制备抗氧化药物中的应用
US3627774A (en) Pyridoxine pyridoxamine and pyridoxal flufenamate salts
EP0096013B1 (en) Salts of erythromycin showing a combined therapeutic activity, process for their preparation and pharmaceutical formulations containing them
NO762064L (ro)
US2367546A (en) Cyclohexenyl alkylamines
US3993776A (en) Anorexigenic process and composition
US2472453A (en) Streptomycin composition of reduced toxicity
CN115259994B (zh) Dpi-有机酸复盐及其制备方法和应用
GB964989A (en) Medicines containing a cysteine derivative
US3461211A (en) Lipotropic compositions and their administration
CA1047926A (en) Antiemetic method
US3079441A (en) 2-hydrazino-octane sulfate
IL43235A (en) Crystalline pivaloyloxymethyl d(-)-alpha-aminobenzylpenicillinate,its production and pharmaceutical compositions containing it